SERA Sera Prognostics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SERA

Price (delayed)

$2.25

Market cap

$88.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.65

Enterprise value

$86.44M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9
Highlights
SERA's EPS is up by 31% year-on-year and by 3% since the previous quarter
The quick ratio has grown by 25% from the previous quarter and by 2% YoY
The gross margin has plunged by 87% from the previous quarter
Sera Prognostics's revenue has plunged by 50% YoY and by 30% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research

Key stats

What are the main financial stats of SERA

SERA stock price

How has the Sera Prognostics stock price performed over time
Intraday
9.76%
1 week
5.14%
1 month
18.42%
1 year
32.35%
YTD
-23.73%
QTD
10.84%

Financial performance

How have Sera Prognostics's revenue and profit performed over time
Revenue
$57,000
Gross profit
-$109,000
Operating income
-$36.61M
Net income
-$32.14M
Gross margin
-191.2%
Net margin
-56,386%
Sera Prognostics's operating margin has shrunk by 101% YoY and by 43% QoQ
Sera Prognostics's net margin has plunged by 97% YoY and by 43% from the previous quarter
The gross margin has plunged by 87% from the previous quarter
Sera Prognostics's revenue has plunged by 50% YoY and by 30% from the previous quarter

Price vs fundamentals

How does SERA's price correlate with its fundamentals

Growth

What is Sera Prognostics's growth rate over time

Valuation

What is Sera Prognostics stock price valuation
P/E
N/A
P/B
1.3
P/S
1,983.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,516.44
SERA's EPS is up by 31% year-on-year and by 3% since the previous quarter
The price to book (P/B) is 41% lower than the 5-year quarterly average of 2.0 and 8% lower than the last 4 quarters average of 1.3
The equity has declined by 29% year-on-year and by 10% since the previous quarter
Sera Prognostics's revenue has plunged by 50% YoY and by 30% from the previous quarter
SERA's P/S is 31% above its 5-year quarterly average of 1378.2 and 13% above its last 4 quarters average of 1594.9

Efficiency

How efficient is Sera Prognostics business performance
SERA's return on sales has dropped by 97% year-on-year and by 43% since the previous quarter
The ROIC has grown by 24% YoY but it has contracted by 8% from the previous quarter
The company's return on equity rose by 20% YoY but it fell by 9% QoQ
The company's return on assets rose by 17% YoY but it fell by 7% QoQ

Dividends

What is SERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SERA.

Financial health

How did Sera Prognostics financials performed over time
The current ratio has grown by 25% from the previous quarter and by 5% YoY
The quick ratio has grown by 25% from the previous quarter and by 2% YoY
Sera Prognostics's debt is 96% less than its equity
SERA's debt to equity is up by 33% QoQ
The equity has declined by 29% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.